FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2300364148> ?p ?o ?g. }

• W2300364148 endingPage "403" @default.
• W2300364148 startingPage "395" @default.
• W2300364148 abstract "OBJECTIVE: We aimed to explore the potential application of circulating microRNA-451 (miR-451) in serum in predicting the resistance to neoadjuvant chemotherapy (NACT) in breast cancer (BC). METHODS: Eighty-two BC patients who underwent NACT were recruited in our study, including 41 NACT-sensitive patients (NACT-sensitive group) and 41 NACT-resistant patients (NACT-resistant group). Additionally, 60 healthy subjects were selected as normal controls. Epirubicin-resistant MCF-7 BC cell line (MCF-7/EPI) and docetaxel-resistant MCF-7 BC cell line (MCF-7/DOC) were cultured in our study. MTT assay was applied to calculate the survival rates of MCF-7 cells, MCF-7/DOC cells and MCF-7/EPI cells. The expression levels of miR-451 in normal controls, NACT-sensitive group, NACT-resistant group, MCF-7 cells, MCF-7/DOC cells and MCF-7/EPI cells were measured by qRT-PCR method. RESULTS: The proliferation rates of both the MCF-7/DOC and MCF-7/EPI cells were significantly restrained at the drug concentration of 10 ng/ml, 50 ng/ml, 100 ng/ml and 200 ng/ml. However, the proliferation rates of MCF-7/DOC and MCF-7/EPI cells both increased significantly at the drug concentration of 500ng/ml. Furthermore, the IC50 of MCF-7/DOC cells was 23.603 ng/ml and the IC50 of MCF-7/EPI cells was 3.209 ng/ml. The relative expression of miR-451 was significantly lower in both the NACT-resistant group and the NACT-sensitive group than the normal control group. We also found that the relative expression level of miR-451 was significantly lower in the NACT-resistant group than that in the NACT-sensitive group. The expression of miR-451 in the MCF-7/EPI and the MCF-7/DOC cell lines was significantly lower than that in the MCF-7 cell lines. CONCLUSION: We supported the view that the relative expression level of miR-451 was lower in the NACT-resistant BC patients, suggesting the circulating miR-451 may have a functional significance in predicting the resistance to NACT in BC patients. We laid a foundation for further research on the resistance to NACT in BC treatment." @default.
• W2300364148 created "2016-06-24" @default.
• W2300364148 creator A5032092477 @default.
• W2300364148 creator A5055551987 @default.
• W2300364148 creator A5062579973 @default.
• W2300364148 creator A5075404039 @default.
• W2300364148 creator A5083837269 @default.
• W2300364148 date "2016-03-30" @default.
• W2300364148 modified "2023-10-17" @default.
• W2300364148 title "Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer" @default.
• W2300364148 cites W1966141689 @default.
• W2300364148 cites W1970970870 @default.
• W2300364148 cites W1989259853 @default.
• W2300364148 cites W1989323945 @default.
• W2300364148 cites W1991930782 @default.
• W2300364148 cites W2001701937 @default.
• W2300364148 cites W2004102172 @default.
• W2300364148 cites W2004512437 @default.
• W2300364148 cites W2024139498 @default.
• W2300364148 cites W2028534873 @default.
• W2300364148 cites W2033948992 @default.
• W2300364148 cites W2038207774 @default.
• W2300364148 cites W2053930149 @default.
• W2300364148 cites W2055161024 @default.
• W2300364148 cites W2059097898 @default.
• W2300364148 cites W2060143849 @default.
• W2300364148 cites W2066633590 @default.
• W2300364148 cites W2073791535 @default.
• W2300364148 cites W2076011743 @default.
• W2300364148 cites W2077731584 @default.
• W2300364148 cites W2079448911 @default.
• W2300364148 cites W2081726107 @default.
• W2300364148 cites W2094895072 @default.
• W2300364148 cites W2095704084 @default.
• W2300364148 cites W2097352128 @default.
• W2300364148 cites W2097760889 @default.
• W2300364148 cites W2099005045 @default.
• W2300364148 cites W2104212366 @default.
• W2300364148 cites W2107860084 @default.
• W2300364148 cites W2118728607 @default.
• W2300364148 cites W2122080063 @default.
• W2300364148 cites W2128054670 @default.
• W2300364148 cites W2129103984 @default.
• W2300364148 cites W2135493442 @default.
• W2300364148 cites W2142492290 @default.
• W2300364148 cites W2147415463 @default.
• W2300364148 cites W2149146896 @default.
• W2300364148 cites W2154040159 @default.
• W2300364148 cites W2161817637 @default.
• W2300364148 cites W2163946434 @default.
• W2300364148 cites W2164990414 @default.
• W2300364148 cites W2167985837 @default.
• W2300364148 cites W2168083077 @default.
• W2300364148 doi "https://doi.org/10.3233/cbm-160578" @default.
• W2300364148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27062696" @default.
• W2300364148 hasPublicationYear "2016" @default.
• W2300364148 type Work @default.
• W2300364148 sameAs 2300364148 @default.
• W2300364148 citedByCount "38" @default.
• W2300364148 countsByYear W23003641482017 @default.
• W2300364148 countsByYear W23003641482018 @default.
• W2300364148 countsByYear W23003641482019 @default.
• W2300364148 countsByYear W23003641482020 @default.
• W2300364148 countsByYear W23003641482021 @default.
• W2300364148 countsByYear W23003641482022 @default.
• W2300364148 countsByYear W23003641482023 @default.
• W2300364148 crossrefType "journal-article" @default.
• W2300364148 hasAuthorship W2300364148A5032092477 @default.
• W2300364148 hasAuthorship W2300364148A5055551987 @default.
• W2300364148 hasAuthorship W2300364148A5062579973 @default.
• W2300364148 hasAuthorship W2300364148A5075404039 @default.
• W2300364148 hasAuthorship W2300364148A5083837269 @default.
• W2300364148 hasConcept C109541995 @default.
• W2300364148 hasConcept C114851261 @default.
• W2300364148 hasConcept C121608353 @default.
• W2300364148 hasConcept C126322002 @default.
• W2300364148 hasConcept C143998085 @default.
• W2300364148 hasConcept C185592680 @default.
• W2300364148 hasConcept C2776694085 @default.
• W2300364148 hasConcept C2780835546 @default.
• W2300364148 hasConcept C2781190966 @default.
• W2300364148 hasConcept C2994423619 @default.
• W2300364148 hasConcept C502942594 @default.
• W2300364148 hasConcept C530470458 @default.
• W2300364148 hasConcept C54355233 @default.
• W2300364148 hasConcept C71924100 @default.
• W2300364148 hasConcept C81885089 @default.
• W2300364148 hasConcept C86803240 @default.
• W2300364148 hasConcept C89423630 @default.
• W2300364148 hasConceptScore W2300364148C109541995 @default.
• W2300364148 hasConceptScore W2300364148C114851261 @default.
• W2300364148 hasConceptScore W2300364148C121608353 @default.
• W2300364148 hasConceptScore W2300364148C126322002 @default.
• W2300364148 hasConceptScore W2300364148C143998085 @default.
• W2300364148 hasConceptScore W2300364148C185592680 @default.
• W2300364148 hasConceptScore W2300364148C2776694085 @default.
• W2300364148 hasConceptScore W2300364148C2780835546 @default.
• W2300364148 hasConceptScore W2300364148C2781190966 @default.

• next